---
title: "ST Sinopep, Vazyme and others establish a new biopharmaceutical company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253164476.md"
description: "According to the Qichacha APP, recently, Nanjing Sinopep Biopharmaceutical Co., Ltd. was established with a registered capital of 20 million yuan. The business scope includes: research and development of bio-based material technology; research and development of industrial enzyme preparations; research and development of biological feed; research and development of biochemical products technology, etc. Qichacha's equity penetration shows that the company is jointly held by Sinopep and Vazyme"
datetime: "2025-08-15T07:46:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253164476.md)
  - [en](https://longbridge.com/en/news/253164476.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253164476.md)
---

# ST Sinopep, Vazyme and others establish a new biopharmaceutical company

According to the Qichacha APP, recently, Nanjing Sinopep Biopharmaceutical Co., Ltd. was established with a registered capital of 20 million yuan. The business scope includes: research and development of bio-based material technology; research and development of industrial enzyme preparations; research and development of biological feed; research and development of biochemical products technology, etc. Qichacha's equity penetration shows that the company is jointly held by Sinopep and Vazyme

### Related Stocks

- [688105.CN](https://longbridge.com/en/quote/688105.CN.md)
- [688076.CN](https://longbridge.com/en/quote/688076.CN.md)

## Related News & Research

- [09:20 ETHaier Signs Four-Year Sponsorship with Al Ahly FC, Becoming the Club's Second Main Sponsor](https://longbridge.com/en/news/287073987.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)